KMDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Kamada Ltd (KMDA) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's strong financial performance, bullish technical indicators, and a recent analyst upgrade with a higher price target suggest positive momentum. While there are no immediate trading signals or significant news catalysts, the stock's fundamentals and technical setup make it a solid long-term investment choice.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. The RSI is neutral at 70.664, and the MACD histogram is negative but contracting, suggesting potential stabilization. Key resistance levels are at $8.6 and $8.781, with support at $8.018 and $7.837.
Analyst upgrade by H.C. Wainwright, raising the price target to $13 from $11 with a Buy rating.
Strong financial performance in Q3 2025, with revenue, net income, EPS, and gross margin all showing significant YoY growth.
No significant news or event-driven catalysts in the recent week.
Lack of recent congress trading data or insider activity.
In Q3 2025, Kamada Ltd reported a 12.63% YoY increase in revenue to $47.01M, a 37.10% YoY increase in net income to $5.296M, and a 28.57% YoY increase in EPS to $0.09. Gross margin improved by 1.82% YoY to 42.04%.
H.C. Wainwright raised the price target to $13 from $11 and maintained a Buy rating, citing the company's decision to discontinue a non-core clinical trial and refocus on its core products as a positive move.
